Research progress in antibody-drug conjugates in ovarian cancer
Antibody-drug conjugates(ADCs)consist of monoclonal antibodies,linkers,and cytotoxic drugs,representing a novel class of anti-cancer agents that combine target specificity with chemotherapeutic efficacy.ADCs have demonstrated significant efficacy not only in breast cancer,gastric cancer and lung cancer,and have also shown clinical benefits in ovarian cancer.This review discussed the structure,mechanism,and applications of ADCs in ovarian cancer,aiming to provide new insights for clinical treatment of ovarian cancer.
antibody-drug conjuagtetargeted therapyovarian cancer
万方数据
维普
